Skip to main content
Log in

Erysipelas in neutropenia of unknown origin, successfully treated with r-metHuG-CSF (filgrastim)

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328–340

    PubMed  Google Scholar 

  2. Bronchud MH, Scarffe JH, Thatcher N (1987) Phase-I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 56:809–813

    PubMed  Google Scholar 

  3. Crawford J, Ozer H, Stoller R (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164–170

    PubMed  Google Scholar 

  4. Dale DC, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurtzberg J, Wang W, Jakubowski A, Winton E, Lalezari P, Robinson W, Glaspy JA, Emerson S, Gabrilove J, Vincent MLAB (1993) A randomized controlled phase-III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 81:2496–2502

    PubMed  Google Scholar 

  5. Gabrilove JL, Jakubowski A, Scher H (1988) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318:1414–1422

    PubMed  Google Scholar 

  6. Trillet-Lenoir V, Green J, Manegold C (1993) Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer 29A: 319–324

    PubMed  Google Scholar 

  7. Wandt H, Seifert M, Falge C, Gallmeier WM (1993) Longterm correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor. Ann Hematol 66:265–266

    PubMed  Google Scholar 

  8. Weite K, Zeidler C, Reiter A, Müller W, Odenwald E, Souza L, Riehm H (1990) Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75:1056–1063

    PubMed  Google Scholar 

  9. Willfort A, Lorber C, Kapiotis S, Sertl S, Hainz R, Kirchweger P, Jäger U, Kyrle PA, Lechner K, Geissler K (1993) Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh-G-CSF). Ann Hematol 66:241–244.10

    PubMed  Google Scholar 

  10. Yokoyama K, Sato T, Nakajima S, Chino M, Komatsumoto S, Nara M (1992) Successful treatment of methimazole-induced agranulocytosis by granulocyte colony-stimulating factor. Am J Hematol 40:76–77

    PubMed  Google Scholar 

  11. Zeidler C, Reiter A, Yakisan E, Koci B, Riehm H, Welte K (1993) Langzeitbehandlung mit rekombinantem humanem Granulozyten-Kolonien stimulierendem Faktor bei Patienten mit schwerer kongenitaler Neutropenie. Klin Padiatr 205:264–271

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller-Lühr, M., Breyer, N., Martin, A. et al. Erysipelas in neutropenia of unknown origin, successfully treated with r-metHuG-CSF (filgrastim). Ann Hematol 69, 97–98 (1994). https://doi.org/10.1007/BF01698490

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01698490

Key words

Navigation